In late 2003, MEDECO, assisted by M/s Pharmaplan GmbH (Germany), commissioned a new line dedicated to the production of Auto-Disable Syringes (0.5 ml) and Insulin syringes (1 ml). The aim was to make available disposable syringes and needles that could not be used more than once especially during immunization. Today, MEDECO's newly innovated patented technology produces over 160 million of these syringes annually for use by UNICEF and Ministries of Health around the world.
MEDECO is a member of the International Association of Safe Injection Technology (IASIT) and has been awarded the ISO 9001:2000, ISO 13485:2003, CE mark and GMP (Good Manufacturing Practices).
MEDECO is the only WHO/UNICEF-approved technology and supplier of Auto Disable Syringes worldwide. An expansion of its facilities in 2006 enabled MEDECO to triple its AD syringe production capacity in order to meet growing international demand.
With certification from all major international qualifying bodies in its field, MEDECO operates to the highest and up to date international quality standards.
MEDECO's production facility in Abu Dhabi's industrial area is a complex of facilities which includes the company headquarters, 2 clean rooms, 2 injection halls, a common packaging area, ETO sterilizers, three laboratories equipped with the latest test equipment using industry-standard protocols. MEDECO employs highly trained technicians who have a wide range of experience in their respective fields.
MEDECO’s market include the UAE, where it is a major supplier to the UAE Ministry of Health and private sector clients.
Furthermore and apart from supplying international bodies such as UNICEF, MEDECO currently exports, through its worldwide distributor network, to GCC countries and to over 40 countries in Africa, the Middle East and Far East Asia.
MEDECO bases its success as a health care supplier on its research, engineering, design and production capabilities. This includes quality management, ensuring that all MEDECO products (Auto Disable Syringes, IV cannulae IV sets and insulines) are produced to the most rigorous specifications.